Corindus Vascular Robotics, Inc. announced today that it has signed a definitive agreement to issue a newly designated Series A convertible preferred stock to a group of existing investors
Corindus Vascular Robotics Inc. announced today that it received 510(k) clearance from the FDA for the first automated robotic movement designed for the CorPath GRX platform.